Billionaire Bill Ackman Just Scooped Up Shares of This Unstoppable Stock
The Motley Fool· 2025-06-13 10:15
Billionaire Bill Ackman and his Pershing Square fund have made some moves recently. Although it hasn't been disclosed in a Form 13-F, the fund stated that it scooped up shares of Amazon (AMZN -0.08%) at an "extremely attractive" price. Although it didn't give details on what the entry point was, I think it's safe to assume that management essentially bought the bottom of the stock market sell-off in April.Although Amazon's stock has risen significantly since then, is there still enough value in the stock to ...
3 Ultra-Reliable Dividend Stocks Yielding Over 3% to Double Up on in June for Passive Income
The Motley Fool· 2025-06-13 10:15
We aren't even halfway through 2025, and already, it has been a roller-coaster year in the stock market. The major indexes incurred steep sell-offs, only to snap back like nothing happened.Some investors may be looking for ways to take their feet off the gas by investing in stocks that distribute a portion of their profits to shareholders through dividends. Dividends are a great way to generate passive income, no matter what the stock market is doing. This can be a good approach for risk-averse investors, f ...
Is Now The Time To Buy Qualcomm Stock?
Forbes· 2025-06-13 10:05
Core Viewpoint - Qualcomm's stock has shown moderate performance with a year-to-date increase of approximately 3% amid U.S.-China trade uncertainties, but the company reported strong Q2 FY'25 results, with revenue up 15% year-over-year to $10.84 billion and earnings per share at $2.85, driven by a rebound in the smartphone market [2][3] Revenue Growth - Qualcomm's revenue has grown at an average rate of 5.3% over the past three years, slightly below the S&P 500's 5.5% growth [5] - In the last 12 months, Qualcomm's revenue increased by 12.1%, from $36 billion to $42 billion, compared to the S&P 500's 5.5% growth [5] - Quarterly revenues rose by 17.5% to $11 billion from $9.4 billion a year prior, outperforming the S&P 500's 4.8% improvement [5] Profitability Metrics - Qualcomm has a price-to-sales (P/S) ratio of 4.2, compared to 3.0 for the S&P 500 [7] - The company's price-to-free cash flow (P/FCF) ratio is 12.4, while the S&P 500 stands at 20.5 [7] - Qualcomm's price-to-earnings (P/E) ratio is 16.2, significantly lower than the S&P 500's 26.4 [7] - The operating margin for Qualcomm is 26.4%, compared to 13.2% for the S&P 500, indicating strong profitability [8] Financial Stability - Qualcomm's debt is $15 billion, with a market capitalization of $176 billion, resulting in a debt-to-equity ratio of 8.5%, lower than the S&P 500's 19.9% [10] - Cash and cash equivalents amount to $14 billion out of $55 billion in total assets, leading to a cash-to-assets ratio of 25.7%, compared to 13.8% for the S&P 500 [10] Downturn Resilience - Qualcomm's stock has shown slightly better performance than the S&P 500 during recent downturns, including a 45.1% decline during the inflation shock of 2022, compared to a 25.4% decline for the S&P 500 [12] - The stock fully recovered to its pre-crisis peak by May 2024 and has since risen to around $160 [12] - Historical performance during the COVID-19 pandemic and the global financial crisis also indicates resilience, with Qualcomm recovering fully from significant declines [12][13] Overall Assessment - Qualcomm's operational performance and financial standing are assessed as very strong across key metrics, making the stock appealing at its current valuation [3][15]
Enliven Therapeutics Announces Updated Positive Data from Phase 1 Clinical Trial of ELVN-001 in CML at EHA 2025 Congress
Prnewswire· 2025-06-13 10:02
Reported cumulative MMR rate of 47% (25 of 53) by 24 weeks with 32% (13 of 41) of patients achieving MMR by 24 weeks, which continues to compare favorably to precedent Phase 1 trials of approved BCR::ABL1 TKIs ELVN-001 continues to demonstrate a favorable safety and tolerability profile across all dose levels with 90 patients enrolled and a median treatment duration of ~29 weeks at cutoffEnliven will host a webcast and conference call today, June 13, at 1:30 p.m. ET BOULDER, Colo., June 13, 2025 /PRNewswire ...
ZKH Group Limited Announces New Share Repurchase Program
Prnewswire· 2025-06-13 10:00
SHANGHAI, June 13, 2025 /PRNewswire/ -- ZKH Group Limited ("ZKH" or the "Company") (NYSE: ZKH), a leading maintenance, repair and operations ("MRO") procurement service platform in China, today announced that its board of directors has authorized a new share repurchase program under which the Company may repurchase up to US$50 million worth of its shares (including American Depositary Shares) over the next 12 months, ending on June 13, 2026.The share repurchases may be effected from time to time on the open ...
ChipMOS ADJUSTS CASH DIVIDEND DISTRIBUTION RATIO TO APPROXIMATELY NT$1.23 PER COMMON SHARE OR APPROXIMATELY US$0.82 PER ADS
Prnewswire· 2025-06-13 10:00
HSINCHU, June 13, 2025 /PRNewswire-FirstCall/ -- ChipMOS TECHNOLOGIES INC. ("ChipMOS" or the "Company") (Taiwan Stock Exchange: 8150 andNasdaq: IMOS), an industry leading provider of outsourced semiconductor assembly and test services ("OSAT"), announced that the Company adjusted the cash dividend distribution ratio from NT$1.20 per common share to approximately NT$1.23 per common share, following the Company's cancellation of treasury shares and the repurchase of shares for transfer to employees, which imp ...
UDR: Rental Market Softening Justifies Recent Underperformance
Seeking Alpha· 2025-06-13 09:57
Shares of UDR, Inc. (NYSE: UDR ) have been a moderate performer over the past year, gaining 6%, as the apartment REIT has weathered turbulence in the sector well, thanks to its focus on legacy markets with less supply. However, shares have not recoveredOver fifteen years of experience making contrarian bets based on my macro view and stock-specific turnaround stories to garner outsized returns with a favorable risk/reward profile. If you want me to cover a specific stock or have a question for an article, j ...
Shareholder Alert: Robbins LLP Informs Investors of the Tempus AI, Inc. Class Action
Prnewswire· 2025-06-13 09:55
SAN DIEGO, June 13, 2025 /PRNewswire/ -- Robbins LLP informs stockholders that a class action was filed on behalf of investors who purchased or otherwise acquired Tempus AI, Inc. (NASDAQ: TEM) common stock between August 6, 2024 and May 27, 2025. Tempus purports to be provide Artificial Intelligence ("AI") enabled precision medicine solutions.For more information, submit a form, email attorney Aaron Dumas, Jr., or give us a call at (800) 350-6003.The Allegations: Robbins LLP is Investigating Allegations th ...
Levi & Korsinsky Reminds Bitfarms Ltd. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of July 8, 2025 - BITF
Prnewswire· 2025-06-13 09:45
NEW YORK, June 13, 2025 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in Bitfarms Ltd. ("Bitfarms Ltd." or the "Company") (NASDAQ: BITF) of a class action securities lawsuit.CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of Bitfarms Ltd. investors who were adversely affected by alleged securities fraud between March 21, 2023 and December 9, 2024. Follow the link below to get more information and be contacted by a member of our team:https://zlk.com/pslra-1/bitfarms-ltd-lawsuit-sub ...
Contact Levi & Korsinsky by August 11, 2025 Deadline to Join Class Action Against Rocket Pharmaceuticals, Inc.(RCKT)
Prnewswire· 2025-06-13 09:45
NEW YORK, June 13, 2025 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in Rocket Pharmaceuticals, Inc. ("Rocket" or the "Company") (NASDAQ: RCKT) of a class action securities lawsuit.CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of Rocket investors who were adversely affected by alleged securities fraud between February 27, 2025 and May 26, 2025. Follow the link below to get more information and be contacted by a member of our team:https://zlk.com/pslra-1/rocket-pharmaceuticals-i ...